[1] |
朱鑫哲, 李浩, 徐华祥, 等. 2021年胰腺癌研究及诊疗新进展[J]. 中国癌症杂志, 2022, 32(1): 1-12.
doi: 10.19401/j.cnki.1007-3639.2022.01.001
|
|
ZHU X Z, LI H, XU H X, et al. Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021[J]. China Oncol, 2022, 32(1): 1-12.
|
[2] |
MIZRAHI J D, SURANA R, VALLE J W, et al. Pancreatic cancer[J]. Lancet, 2020, 395(10242): 2008-2020.
doi: S0140-6736(20)30974-0
pmid: 32593337
|
[3] |
SHEN Y J, YU X C, ZHU L W, et al. Transfer RNA-derived fragments and tRNA halves: biogenesis, biological functions and their roles in diseases[J]. J Mol Med, 2018, 96(11): 1167-1176.
doi: 10.1007/s00109-018-1693-y
|
[4] |
JIN L, ZHU C F, QIN X H. Expression profile of tRNA-derived fragments in pancreatic cancer[J]. Oncol Lett, 2019, 18(3): 3104-3114.
doi: 10.3892/ol.2019.10601
pmid: 31452788
|
[5] |
LI J, JIN L, GAO Y, et al. Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma[J]. J Clin Lab Anal, 2021, 35(5): e23742.
|
[6] |
DROUILLARD A, MANFREDI S, LEPAGE C, et al. Epidemiology of pancreatic cancer[J]. Bull Cancer, 2018, 105(1): 63-69.
doi: 10.1016/j.bulcan.2017.11.004
|
[7] |
CABASAG C J, FERLAY J, LAVERSANNE M, et al. Pancreatic cancer: an increasing global public health concern[J]. Gut, 2022, 71(8): 1686-1687.
|
[8] |
YU M Q, LU B J, ZHANG J S, et al. tRNA-derived RNA fragments in cancer: current status and future perspectives[J]. J Hematol Oncol, 2020, 13(1): 121.
doi: 10.1186/s13045-020-00955-6
|
[9] |
XIE Y Y, YAO L P, YU X C, et al. Action mechanisms and research methods of tRNA-derived small RNAs[J]. Signal Transduct Target Ther, 2020, 5(1): 109.
|
[10] |
CUI Y Y, HUANG Y, WU X W, et al. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer[J]. J Cell Physiol, 2019, 234(6): 8740-8751.
doi: 10.1002/jcp.27533
pmid: 30362543
|
[11] |
ZENG T Y, HUA Y J, SUN C X, et al. Relationship between tRNA-derived fragments and human cancers[J]. Int J Cancer, 2020, 147(11): 3007-3018.
doi: 10.1002/ijc.v147.11
|
[12] |
HUANG B Q, YANG H P, CHENG X X, et al. tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer[J]. Cancer Res, 2017, 77(12): 3194-3206.
doi: 10.1158/0008-5472.CAN-16-3146
pmid: 28446464
|
[13] |
LIN C F, ZHENG L W, HUANG R L, et al. tRFs as potential exosome tRNA-derived fragment biomarkers for gastric carcinoma[J]. Clin Lab, 2020, 66(6).
|
[14] |
ZHANG M M, LI F F, WANG J, et al. tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer[J]. Onco Targets Ther, 2019, 12: 6371-6383.
doi: 10.2147/OTT
|
[15] |
董磊, 张仲妍. 靶向IRF2的miR-1290对非小细胞肺癌细胞增殖、侵袭的调控作用及其机制研究[J]. 中国癌症杂志, 2020, 30(1): 32-40.
|
|
DONG L, ZHANG Z Y. Regulatory effect of miR-1290 targeting IRF2 on proliferation and invasion of non-small cell lung cancer cells and its related mechanism[J]. China Oncol, 2020, 30(1): 32-40.
|
[16] |
朱海鹏, 胡军, 姜敏, 等. GOLM1调控PI3K/AKT/mTOR信号转导通路促进肺腺癌细胞增殖、侵袭和迁移的机制研究[J]. 中国癌症杂志, 2022, 32(3): 207-217.
doi: 10.19401/j.cnki.1007-3639.2022.03.003
|
|
ZHU H P, HU J, JIANG M, et al. A study on mechanism of GOLM1 regulating PI3K/AKT/mTOR signaling pathway to promote proliferation, invasion and migration of lung adenocarcinoma cells[J]. China Oncol, 2022, 32(3): 207-217.
|
[17] |
EBRAHIMI S, HOSSEINI M, SHAHIDSALES S, et al. Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer[J]. Curr Med Chem, 2017, 24(13): 1321-1331.
doi: 10.2174/0929867324666170206142658
pmid: 28176634
|